The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment.
D000215:Acylation; D000293:Adolescent; D000328:Adult; D002648:Child; D003545:Cysteine / Q000652:urine; D003555:Cystinuria / Q000188:drug therapy*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology; D004487:Edema / Q000150:complications; D005260:Female; D006801:Humans; D007019:Hypoproteinemia / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000139:chemically induced; D012709:Serum Albumin; D014508:Urea / Q000097:blood; D014545:Urinary Calculi / Q000188:drug therapy
D012709:Serum Albumin; D014508:Urea; D011239:Prednisolone; D010396:Penicillamine; D003545:Cysteine